Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders
Author(s) -
David J. Araten,
H. Michael Belmont,
Julia Schaefer-Cutillo,
Arjun Iyengar,
Aprajita Mattoo,
Ramachandra C. Reddy
Publication year - 2020
Publication title -
american journal of case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.247
H-Index - 18
ISSN - 1941-5923
DOI - 10.12659/ajcr.927418
Subject(s) - medicine , covid-19 , monoclonal antibody , complement (music) , hematologic disorders , antibody , hematological disorders , virology , immunology , infectious disease (medical specialty) , biology , disease , biochemistry , complementation , outbreak , gene , phenotype
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom